Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves’ Disease

BACKGROUND: Radioactive iodine (RAI) therapy is a successful therapeutic modality for Graves’ disease. However, RAI therapy can fail, and RAI therapy after antithyroid drugs (ATDs) has a lower remission rate. Therefore, many patients require repeated RAI therapy. This study investigated the clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Min Joo, Cho, Sun Wook, Kim, Ye An, Choi, Hoon Sung, Park, Young Joo, Park, Do Joon, Cho, Bo Youn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262691/
https://www.ncbi.nlm.nih.gov/pubmed/35709827
http://dx.doi.org/10.3803/EnM.2022.1418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262691/
https://www.ncbi.nlm.nih.gov/pubmed/35709827
http://dx.doi.org/10.3803/EnM.2022.1418

Ejemplares similares